好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Multi-Center, Placebo-Controlled, Double-Blind Trial To Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson[apos]s Disease
Movement Disorders
(-)
004
Authors/Disclosures
Joseph H. Friedman, MD, FAAN (Butler Hospital) No disclosure on file
Bernard M. Ravina, MD, MSCE (Voyager Therapeutics, Inc.) Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis.
Roger G. Mills, MD No disclosure on file
Hilde Williams Hilde Williams has received personal compensation for serving as an employee of Vima Therapeutics, Inc.. The institution of Hilde Williams has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ProJenX Inc.. Hilde Williams has stock in PharmaStory Corp.. Hilde Williams has received intellectual property interests from a discovery or technology relating to health care.
Rachel Salazar, PT (Columbia University) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Francois Tison, MD, PhD (CHU Bordeaux) No disclosure on file
David J. Burn, MD (Regional Neuroscience Centre) No disclosure on file